Prognostic value and development of psycho-social factors and functional aspects in elderly patients with higher risk MDS and AMl. A multi-center observational study.
Recruiting
- Conditions
- C92.0D46Acute myeloblastic leukaemia [AML]Myelodysplastic syndromes
- Registration Number
- DRKS00003601
- Lead Sponsor
- Medizinische Universitätsklinik Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Higher risk MDS/AML, age >/= 60 years, written informed consent, anticipated compliance and geographic proximity for follow-up assessments
Exclusion Criteria
other malignant diseases not in remission, impaired mental status with inability to fill out questionnaires and to obey simple demands. Trial participation for medical therapy is NOT an exclusion criterion
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival within a 2.5 year observation period. Components of a comprehensive geriatric assessment will be evaluated for their prognostic value.
- Secondary Outcome Measures
Name Time Method Independence (Barthel Index), Quality of Life (EORTC QLQ C 30), psychologigal distress (HADS) prior to treatment initiation, and every 3 months for 1 year.